NICE Publishes new COVID-19 Guidelines on Cystic Fibrosis, COPD and Dermatological Conditions

News Release: NICE publishes new COVID-19 guidelines on cystic fibrosis, chronic obstructive pulmonary disease (COPD) and dermatological conditions – National Institute for Health and Care Excellence

See New COVID-19 Rapid Guidelines: Community-based care of patients with chronic obstructive pulmonary disease (COPD) AND Cystic fibrosis AND Dermatological conditions treated with drugs affecting the immune response

See Other COVID-19 Rapid Guidelines: Severe asthma AND Managing suspected or confirmed pneumonia in adults in the community AND Rheumatological autoimmune, inflammatory and metabolic bone disorders AND Managing symptoms (including at the end of life) in the community AND Critical care in adults AND Hematopoietic stem cell transplantation AND Dialysis service delivery AND Delivery of radiotherapy AND Delivery of systemic anticancer treatments